BioPharma Asia convention 2016

Asia has long been considered an emerging market to many in the biopharmaceutical market. Her efforts to make a deeper impact in the global biopharmaceutical market have not gone unnoticed by its numerous efforts to advance biosimilars, NCEs, immunotherapies and other biologics in key regions such as Korea, China, India, Japan and ASEAN.

Some examples include:

• The Center for Drug Evaluation of Chinese FDA published its “draft technical guidelines for research, development and evaluation of biosimilars” in October 2014.
   
• Ministry of Food & Drug Safety (Korea) pledged its support to develop its biopharmaceutical sector by announcing the globalisation of its vaccines business, entailing a national goal to become the world’s fifth largest vaccine country by 2020.
   
• India’s CDSCO issued its new trial regulations and upped its number of approved clinical trials.
   
• ASEAN’s goal to harmonise and standardise its drug registrations is not too far off.
   
• Singapore has committed S$16.1 billion in continued support of research, innovation and enterprise activities between 2011 and 2015.

That’s where BioPharma Asia Convention 2016 comes in. Together with leading experts who live and breathe Asia’s opportunities, BioPharma Asia Convention 2016 will explore both the tapped and untapped markets of Asia and present the progress of Asia’s biopharmaceutical industry.

From its humble beginnings as BioMedical Asia in 2008, BioPharma Asia Convention has attracted close to 20,000 attendees over the past 8 years. Many return to this annual gathering in March with networking and learning objectives in mind and leave with new knowledge, new contacts and new business opportunities to explore for more profitable business. We offer a broad spectrum of content that is multi-faceted yet targeted. And we offer sponsorship and exhibition packages designed to help you meet your business priorities – be it branding, lead generation, thought leadership or strategising your latest product launch.

Backed by sponsors, partners and industry stakeholders who stay true to the BioPharma Asia Convention brand, it is a testimony of how we can only be bigger and better as we mature along with Asia’s biopharmaceutical industry.

Join more than 2,000 attendees at Asia’s most important  biopharmaceutical gathering.

Welcome to Biopharma Asia Convention 2016.